Tesaro shares soared 39 percent Friday upon a Bloomberg report that the pharmaceutical company will explore the opportunity of a sale.
This comes exactly one week after Tesaro fell more than 20 percent during after-hours trading after the release of drug trial results. A spokesperson declined to comment.
This story is developing. Please check back for updates.